S Bukhari, BS Henick, RJ Winchester, S Lerrer… - Cell Reports …, 2023 - cell.com
PD-1 is an inhibitory receptor in T cells, and antibodies that block its interaction with ligands
augment anti-tumor immune responses. The clinical potential of these agents is limited by …